Back to Authors

Schmitt, Jennifer J

Mayo Clinic

From the Divisions of *Gynecologic Surgery and †Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.

Citations 3

Vaginal Hysterectomy: Historical Footnote or Viable Route?
Gebhart, John B. , Schmitt, Jennifer, Baker, Mary V. , Occhino, John A. , McGree, Michaela E. , Weaver, Amy L. , Dowdy, Sean C. , Schmitt, Jennifer J, Bakkum‐Gamez, Jamie N. , Pasupathy, Kalyan S.

Obstetrics & Gynecology | July 23, 2020 | Volume: 136 | Issue: 2 | Pages: 426-426

10.1097/aog.0000000000004030 Get It

Prospective Outcomes of a Pelvic Floor Rehabilitation Program Including Vaginal Electrogalvanic Stimulation for Urinary, Defecatory, and Pelvic Pain Symptoms
Schmitt, Jennifer, Singh, Ruchira, Weaver, Amy L. , Mara, Kristin C. , Harvey-Springer, Randina R., Fick, Felecia R., Occhino, John A. , Schmitt, Jennifer J, Mara, Kristin C

Female Pelvic Medicine & Reconstructive Surgery | January 18, 2017 | Volume: 23 | Issue: 2 | Pages: 108-113

10.1097/spv.0000000000000371 Get It

Objectives This study evaluated our experience after implementing a pelvic floor rehabilitation program including behavioral modification, biofeedback, and vaginal electrogalvanic stimulation (EGS). Methods This prospective cohort study evaluated outcomes of patients with pelvic floor dysfunction (urinary or defecatory dysfunction, pelvic pain/dyspareunia) who underwent pelvic floor rehabilitation. Patients received 4 to 7 sessions (1 every 2 weeks) including biofeedback and concluded with 30 minutes of vaginal EGS. Surveys assessed subjective changes in symptoms; success was evaluated using a 10-point visual analog scale (VAS) at the final session (10 = most successful). Paired comparisons of responses at baseline and final treatment were evaluated. Results Ninety-four patients were followed up through therapy completion. Treatment indications included urinary (89.4%), defecatory (33.0%), and pelvic pain or dyspareunia (30.9%); 44.7% of patients had a combination of indications. Among women with urinary symptoms, the percentage reporting leakage decreased from 92.9% to 79.3% (P = 0.001), leakage at least daily decreased from 69.0% to 39.5% (P < 0.001), daily urgency with leakage decreased from 42.7% to 19.5% (P = 0.001), daily urgency without leakage decreased from 41.5% to 18.3% (P < 0.001), and median VAS rating (0 = not at all, 10 = a great deal) of daily life interference decreased from 5 to 1.5 (P < 0.001). The median success ratings were 8, 8, and 7 for treatment of urinary symptoms, pelvic pain/dyspareunia, and bowel symptoms, respectively. Conclusions An aggressive pelvic rehabilitation program including biofeedback with vaginal EGS had a high rate of self-reported subjective success and satisfaction and should be considered a nonsurgical treatment option in patients with pelvic floor dysfunction.